JOINN Laboratories (China) Co., Ltd. has formalised the establishment of a Strategic Development Committee under its Board of Directors, aiming to enhance strategic planning and improve the efficiency and quality of major investment decisions.

Key governance features • Composition: The committee will comprise at least four directors, including a minimum of one independent director. The company chairperson will serve as committee chair. • Tenure: Committee members serve concurrent three-year terms with the Board; consecutive service of an independent director is capped at six years. • Supporting structure: An investment review team, headed by the general manager and supported by up to two deputy heads, will provide preliminary project assessments and written opinions to the committee.

Principal responsibilities • Formulate and recommend long-term development strategies. • Evaluate and advise on major investment and financing plans, capital operations, and asset transactions that fall under Board or shareholder approval. • Monitor the execution of approved strategic and investment initiatives. • Handle additional matters authorised by the Board.

Decision-making mechanics • Meetings require at least two-thirds attendance and resolutions pass with a simple majority. • Sessions may be held on-site or via tele-/video-conference; members unable to attend may vote by proxy. • Minutes must accurately document discussions, be signed by attending members, and archived for no less than ten years. • The committee can engage external advisers at the company’s expense to secure independent professional opinions.

Effective date The Terms of Reference take effect upon Board approval, with the document dated June 2026, underscoring JOINN’s commitment to robust corporate governance and disciplined strategic execution.